Essais liés3clinical trials
VilleHolonlocalisation
PaysIsraellocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT04957719

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
Selatogrel Maladie coronarienne Phase 3 NCT04957719 SOS-AMI — Selatogrel Outcome Study in Suspected Acute Myocardial Infarction ENROLLING_BY_INVITATION
TAK-935 Épilepsie Phase 2 NCT03650452 ELEKTRA — A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies COMPLETED
Soticlestat Épilepsie Phase 2 NCT03635073 Endymion 1 — A Study of Soticlestat in Adults and Children With Rare Epilepsies TERMINATED